News

Deal Announcements

Celera Group Acquires Atria Genetics For $33 Million

Friday, September 21, 2007 5:00:00 AM PDT | VentureDeal Staff
ROCKVILLE, MD -- Biotech company Celera Group (NYSE: CRA) announced that it has signed a definitive agreement to acquire Atria Genetics, Inc. for $33 million in an all cash transaction.

Atria has a line of human leukocyte antigen testing products that are helpful for identifying potential donors in the matching process for bone marrow transplantation.

Celera already had a relationship with Atria, but the acquisition will allow Celera to retain a higher percentage of Atria's marketing revenues in its agreement with Abbott Molecular.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1